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Abstract
Multidrug-resistant Salmonella infection is a global problem, and carbapenems may represent the last therapeutic choice. We report a
case of infection caused by ceftriaxone-resistant and ciprofloxacin-resistant Salmonella enterica serotype Typhimurium. A blaCMY-2-con-
taining Tn6092, located on a self-transferable IncI1 plasmid, was found in all isolates derived from the patient. During ertapenem treat-
ment, the strain developed carbapenem resistance. Apart from the OmpD deficiency found in all isolates, the strain further developed
OmpC deficiency through a single gene mutation, and became carbapenem-resistant. Salmonella appears to be very plastic in developing
antimicrobial resistance. Care must be taken by physicians when treating multidrug-resistant Salmonella infection.
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Abstract
We report here on the first identification of Shigella flexneri subserotype 1c in China. We also report the emergence of resistance to
ciprofloxacin and third-generation cephalosporins in this subserotype 1c for the first time. Isolates of seven strains circulating in China
yielded three new sequence types and seven pulsed-field gel electrophoresis patterns, thus demonstrating the existence of high genetic
diversity within the isolates. Overall, the seven isolates showed reduced susceptibility to ciprofloxacin; one isolate was ciprofloxacin
resistant, whilst another developed resistance to ciprofloxacin, norfloxacin, cefotaxime and ceftriaxone.
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